RegulaciónFuente primaria

DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests

A skin cancer testing company formerly known as DermTech, Inc. has agreed to settle allegations that it violated the False Claims Act by knowingly submitting false claims for unreliable skin cancer tests to the Medicare program. DermTech is now liquidating as DTech Liquidating Inc. after filing for Chapter 11 bankruptcy in the District of Delaware in June 2024. As part of the resolution announced today, the...

Se muestra el contenido original; la traduccion localizada aun no esta disponible.

Qué ocurrió

A skin cancer testing company formerly known as DermTech, Inc. has agreed to settle allegations that it violated the False Claims Act by knowingly submitting false claims for unreliable skin cancer tests to the Medicare program. DermTech is now liquidating as DTech Liquidating Inc. after filing for Chapter 11 bankruptcy in the District of Delaware in June 2024. As part of the resolution announced today, the...

Por que importa

The development may change operating conditions or market expectations around Regulation. Further confirmation and measurable outcomes matter.

Entidades afectadas

Ver evidencia

2 articulos · 1 informe original · 1 independientes

  1. U.S. Department of JusticeFuente primaria · Respalda · EN · 100%
    DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
  2. U.S. Department of JusticeFuente primaria · Respalda · EN · 80%
    DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests

Afirmaciones

  • DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests Observado

Conflictos

No se detectaron conflictos importantes en la evidencia disponible.

Cronología

  1. Primera publicación

Movimiento del mercado posterior al evento

La reacción del mercado aún no está disponible para este activo y periodo.

Explicación de puntuaciones

Confianza · fórmula confidence-2.1.0
Fiabilidad de fuentes97
Corroboración independiente51
Evidencia primaria100
Coherencia de afirmaciones82
Confianza de extracción82
Calidad de atribución90
Impacto · fórmula impact-2.1.0
Magnitud del evento45
Relevancia de mercado88
Importancia de entidades42
Alcance del mercado48
Novedad60
Urgencia52
capital magnitude100
Clasificación · fórmula rank-1.0.0
Factor de confianza0.9235
Factor de actualidad0.9099
Bono de urgencia0
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests | IntelCap